Alternativa al tratamiento quirúrgico en el carcinoma basocelular en la población anciana: imiquimod 5% crema

Revista Española de Geriatría y Gerontología - Tập 44 - Trang 94-97 - 2009
Salvador Antonio Arias Santiago1, Ricardo Ruiz Villaverde2, Pilar Burkhardt Pérez1, Ramón Naranjo Sintes1
1Servicio Dermatología Hospital Clínico San Cecilio de Granada, España
2Servicio Dermatología Complejo Hospitalario de Jaén, España

Tài liệu tham khảo

Goldberg, 1996, Basal cell carcinoma, Lancet, 347, 663, 10.1016/S0140-6736(96)91208-8

Buendia Eisman, 2002, Epidemiología del cáncer cutáneo no melanoma, Piel, 17, 3, 10.1016/S0213-9251(02)72523-9

Oldfield, 2005, Imiquimod: in superficial basal cell carcinoma, Am J Clin Dermatol, 6, 195, 10.2165/00128071-200506030-00006

Beutner, 1999, Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream, J Am Acad Dermatol, 41, 1002, 10.1016/S0190-9622(99)70261-6

Schulze, 2005, Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe, Br J Dermatol, 152, 939, 10.1111/j.1365-2133.2005.06486.x

Burkhardt Pérez, 2007, Basal cell carcinoma: Treatment with imiquimod, Int J Dermatol, 46, 539, 10.1111/j.1365-4632.2007.03230.x

Ezughah, 2008, A randomized parallel study to assess the safety and efficacy of two different dosing regimens of 5% imiquimod in the treatment of superficial basal cell carcinoma, J Dermatolog Treat, 19, 111, 10.1080/09546630701557965

Quirk, 2006, Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks, Australas J Dermatol, 47, 258, 10.1111/j.1440-0960.2006.00313.x

Rodríguez Caravaca, 1998, Validez del diagnóstico clínico del carcinoma basocelular, Piel, 6, 273